至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Impaired Immune Response to COVID-19 Vaccination in Patients with B-Cell Malignancies after CD19 CART Cell Therapy

Blood Adv. 2021-12; 
Saurabh Dahiya, Tim Luetkens, Forat Lutfi, Stephanie V Avila, Thierry Iraguha, Philip J Margiotta, Kim G Hankey, Patricia Lesho, Jennie Y Law, Seung Tae Lee, John W Baddley, Mehmet Hakan Kocoglu, Jean Yared, Nancy M Hardy, Aaron P Rapoport, Djordje Atanackovic
Products/Services Used Details Operation
Gene Synthesis … 10. Ram, R., et al., Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or … Neutralization Antibody Detection Kit (GenScript Biotech … circulating neutralizing antibodies against SARS-CoV-2 that block the interaction between the … Get A Quote

摘要

关键词